Book contents
- Frontmatter
- Contents
- List of contributors
- Preface
- 1 Basic physical principles of body diffusion-weighted MRI
- 2 Diffusion-weighted MRI of the liver
- 3 Diffusion-weighted MRI of diffuse renal disease and kidney transplant
- 4 Diffusion-weighted MRI of focal renal masses
- 5 Diffusion-weighted MRI of the pancreas
- 6 Diffusion-weighted MRI of the prostate
- 7 Breast applications of diffusion-weighted MRI
- 8 Diffusion-weighted MRI of lymph nodes
- 9 Diffusion-weighted MRI of female pelvic tumors
- 10 Diffusion-weighted MRI of the bone marrow and the spine
- 11 Diffusion-weighted MRI of soft tissue tumors
- 12 Evaluation of tumor treatment response with diffusion-weighted MRI
- 13 Diffusion-weighted MRI: future directions
- Index
- References
12 - Evaluation of tumor treatment response with diffusion-weighted MRI
Published online by Cambridge University Press: 10 November 2010
- Frontmatter
- Contents
- List of contributors
- Preface
- 1 Basic physical principles of body diffusion-weighted MRI
- 2 Diffusion-weighted MRI of the liver
- 3 Diffusion-weighted MRI of diffuse renal disease and kidney transplant
- 4 Diffusion-weighted MRI of focal renal masses
- 5 Diffusion-weighted MRI of the pancreas
- 6 Diffusion-weighted MRI of the prostate
- 7 Breast applications of diffusion-weighted MRI
- 8 Diffusion-weighted MRI of lymph nodes
- 9 Diffusion-weighted MRI of female pelvic tumors
- 10 Diffusion-weighted MRI of the bone marrow and the spine
- 11 Diffusion-weighted MRI of soft tissue tumors
- 12 Evaluation of tumor treatment response with diffusion-weighted MRI
- 13 Diffusion-weighted MRI: future directions
- Index
- References
Summary
Abbreviations
Introduction
Prediction and detection of therapeutic response, as well as characterization of residual disease, are very important for effective cancer therapy. Current assessment of tumor treatment response relies on evaluating changes in the maximal cross-sectional area or the diameter of the tumor, weeks to months after the conclusion of a therapeutic protocol. Several non-invasive imaging methods, such as computed tomography (CT), positron-emission tomography (PET), single-photon emission computerized tomography (SPECT), magnetic resonance spectroscopy (MRS), contrast-enhanced MRI and perfusion, and diffusion-weighted magnetic resonance imaging (DWI) are being evaluated for assessing early therapeutic responses that are independent of late changes in tumor volume.
DWI is a well-known diagnostic tool to evaluate central nervous system pathologies. The primary metric used in DWI is the apparent diffusion coefficient (ADC). The first reported evaluation of mean tumor ADC following chemotherapy of an animal model was performed by Ross et al. in 1994, who studied the effect of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) treatment on orthotopic 9L glioma in a rat model. For many years, the use of DWI was limited to the brain.
- Type
- Chapter
- Information
- Extra-Cranial Applications of Diffusion-Weighted MRI , pp. 172 - 197Publisher: Cambridge University PressPrint publication year: 2010